BENOXINATE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Benoxinate Hydrochloride patents expire, and what generic alternatives are available?
Benoxinate Hydrochloride is a drug marketed by Sola Barnes Hind and is included in one NDA.
The generic ingredient in BENOXINATE HYDROCHLORIDE is benoxinate hydrochloride. There is one drug master file entry for this compound. Additional details are available on the benoxinate hydrochloride profile page.
Summary for BENOXINATE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 84 |
Clinical Trials: | 4 |
Patent Applications: | 521 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BENOXINATE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for BENOXINATE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Alexandria University | N/A |
Zagazig University | Phase 3 |
Cairo University | Phase 3 |
US Patents and Regulatory Information for BENOXINATE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sola Barnes Hind | BENOXINATE HYDROCHLORIDE | benoxinate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 084149-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |